Binovi Technologies Corp. (BNVIF)
Binovi Technologies Corp. operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $13,307. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -8790.2%. Its beta of 0.21 implies it has historically moved less than the broad market.
Binovi Technologies Corp. specializes in developing, producing, and marketing innovative hardware and software solutions that address visual and neuro-cognitive processing challenges. These technologies are designed to diagnose, enhance, and remediate visual perception disorders, with the company operating across Canada, the United States, and on an international scale. Its current product portfolio includes Binovi Touch, a dedicated instrument for vision therapy and training; Binovi Pro, a comprehensive platform that empowers professionals and trainers to manage patient and athlete vision training regimens, monitor progress, and assign tailored protocols; Binovi Coach, which provides users with clear multimedia guidance to complete assigned activities; and Binovi Academy, an educational resource hub. Additionally, the company is actively developing Binovi Agile and Binovi Connect, with the latter intended as a web-based video conferencing solution to connect consumers directly with vision care professionals. The company, previously known as Eyecarrot Innovations Corp., officially changed its name to Binovi Technologies Corp. in June 2020. Its headquarters are situated in Vancouver, Canada.
Binovi Technologies Corp. is most often compared with the following Healthcare names: